Investing.com - Financial Markets Worldwide

DongKoo Bio & Pharma Co Ltd (006620)

KOSDAQ
Currency in KRW
5,100
+80(+1.59%)
Closed·
006620 Scorecard
Full Analysis
Management has been aggressively buying back shares
006620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
5,0305,100
52 wk Range
4,3007,290
Key Statistics
Edit
Bid/Ask
5,080.00 / 5,100.00
Prev. Close
5,020
Open
5,050
Day's Range
5,030-5,100
52 wk Range
4,300-7,290
Volume
26.05K
Average Volume (3m)
67.62K
1-Year Change
-26.09%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
006620 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 4
Prominent player in the Pharmaceuticals industry
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

DongKoo Bio & Pharma Co Ltd Company Profile

DongKoo Bio & Pharma Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company provides prescription drugs, such as antihistamines, dermatological oral medications, ophthalmic solutions, skeletal muscle relaxants, anti-inflammatory enzymes, antivirals, antibacterial agents, and for the treatment of allergies, liver diseases, mental illnesses, obesity, brain nervous, and endocrine systems; over-the-counter medicines, such as dermatological external preparations, antifungal agents, active probiotic intestinal supplements, antipyretic anti-inflammatory analgesics, and for the treatment of the respiratory, digestive, genitourinary, and circulatory systems; and quasi-drugs. It offers cosmetic products under the CELL BLOOM brand; MediBloom MD Lotion/Cream for wound treatment; and medical devices for skin therapy, aesthetic, scalp care, and skin diagnosis. In addition, the company develops DKB15003 for dyslipidemia; DKB17001 for BPH/OAB; DKB17002 for Lumbago; DKB19001 for hypertension/dyslipidemia; DKB19002, DKB20001, DKB20002, DKB20004, DKB1903, DKB1903C, and DKB2001 for diabetes; DKB19003 for allergic rhinitis; DKB20003 for venous lymphatic insufficiency; NCP112 for atopic dermatitis; DKB1904 for allergy/dermatitis; DKB1801 for acne; and DKB1902 and DKB2014 for psoriasis. Further, it engages in new technology, financial, pharmaceutical marketing, and agency businesses. The company was formerly known as DongKoo Pharm Co., Ltd. and changed its name to DongKoo Bio & Pharma Co., Ltd. in January 2014. The company was founded in 1970 and is headquartered in Seoul, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
393
Market
South Korea

Compare 006620 to Peers and Sector

Metrics to compare
006620
Peers
Sector
Relationship
P/E Ratio
−45.3x4.0x−0.5x
PEG Ratio
0.370.010.00
Price/Book
1.4x0.8x2.6x
Price / LTM Sales
0.6x0.6x3.3x
Upside (Analyst Target)
-28.6%43.5%
Fair Value Upside
Unlock17.2%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -111.93%
Dividend Yield
2.35%
Industry Median 0.93%
Annualised payout
120.00
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-25.18 / --
Revenue / Forecast
58.68B / --
EPS Revisions
a
a
Unlock
Last 90 days

006620 Income Statement

FAQ

What Stock Exchange Does DongKoo Bio Pharma Trade On?

DongKoo Bio Pharma is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for DongKoo Bio Pharma?

The stock symbol for DongKoo Bio Pharma is "006620."

What Is the DongKoo Bio Pharma Market Cap?

As of today, DongKoo Bio Pharma market cap is 137.91B.

What Is DongKoo Bio Pharma's Earnings Per Share (TTM)?

The DongKoo Bio Pharma EPS (TTM) is -111.93.

From a Technical Analysis Perspective, Is 006620 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has DongKoo Bio Pharma Stock Split?

DongKoo Bio Pharma has split 1 times.

How Many Employees Does DongKoo Bio Pharma Have?

DongKoo Bio Pharma has 393 employees.

What is the current trading status of DongKoo Bio Pharma (006620)?

As of 09 Aug 2025, DongKoo Bio Pharma (006620) is trading at a price of 5,100.00, with a previous close of 5,020.00. The stock has fluctuated within a day range of 5,030.00 to 5,100.00, while its 52-week range spans from 4,300.00 to 7,290.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.